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Abstract
Background:  In sub-Saharan Africa, Plasmodium falciparum malaria in pregnancy presents an
enormous diagnostic challenge. The epidemiological and clinical relevance of the different types of
malaria diagnosis as well as risk factors associated with malaria infection at delivery were
investigated.
Method:  In a cross-sectional survey, 306 women reporting for delivery in the Mutenegene
maternity clinic, Fako division, South West province, Cameroon were screened for P. falciparum in
peripheral blood, placental blood and placental tissue sections by microscopy. Information relating
to the use of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine,
history of fever attack, infant birth weights and maternal anaemia were recorded.
Results: Among these women, P. falciparum infection was detected in 5.6%, 25.5% and 60.5% of
the cases in peripheral blood, placental blood and placental histological sections respectively.
Placental histology was more sensitive (97.4%) than placental blood film (41.5%) and peripheral
blood (8.0%) microscopy. In multivariate analysis, age (≤ 20 years old) (OR = 4.61, 95% CI = 1.47
– 14.70), history of fever attack (OR = 2.98, 95% CI = 1.58 – 5.73) were significant risk factors
associated with microscopically detected parasitaemia. The use of ≥ 2 SP doses (OR = 0.18, 95%
CI = 0.06 – 0.52) was associated with a significant reduction in the prevalence of microscopic
parasitaemia at delivery. Age (>20 years) (OR = 0.34, 95% CI = 0.15 – 0.75) was the only significant
risk factor associated with parasitaemia diagnosed by histology only in univariate analysis.
Microscopic parasitaemia (OR = 2.74, 95% CI = 1.33–5.62) was a significant risk factor for maternal
anaemia at delivery, but neither infection detected by histology only, nor past infection were
associated with increased risk of anaemia.
Conclusion: Placenta histological examination was the most sensitive indicator of malaria infection
at delivery. Microscopically detected parasitaemia was associated with increased risk of maternal
anaemia at delivery, but not low-grade parasitaemia detected by placental histology only.
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Background
Malaria due to Plasmodium falciparum infection during
pregnancy is a serious public health problem in sub-Saha-
ran Africa. One woman in four has evidence of placental
infection at the time of delivery [1,2]. It is well known that
infection with malaria during pregnancy leads to the
selective adherence of infected erythrocytes (IEs) in the
placenta [3-5]. Plasmodium falciparum erythrocyte mem-
brane protein 1 (var2csa PfEMP1) is the principal chon-
droitin sulfate A (CSA) binding ligand mediating
placental sequestration of IEs [6]. Consequently higher
numbers of IEs containing mature trophozoite and sch-
izont stage parasites may be found in the placenta [4], to
higher densities than in the peripheral circulation.
Sequestration of parasites in the intervillous spaces (IVS),
contributes to maternal morbidity, low birth weight, and
preterm delivery [1,7]. Moreover, malaria in pregnancy is
an important cause of severe anaemia in pregnant African
women [8].
Placental malaria (PM) is one of the major features of
malaria during pregnancy and has been widely used as a
standard indicator to characterize malaria infection in epi-
demiologic investigations [9]. A number of factors influ-
ence the prevalence of malaria in pregnant women,
including maternal age, gravidity, use of prophylaxis,
nutrition, host genetics, level of anti-parasite immunity,
as well as parasite genetics and transmission rates [10].
The prevalence and risk factors of placental malaria in
sub-Saharan Africa have been assessed based on different
definitions of placental malaria using diverse techniques
of sample collection and analysis [9]. Some studies based
their definition on the presence of malaria parasite and/or
pigments in blood smears from placental blood [10-13].
Others based their definition on histological findings
[7,14-16], histidine-rich-protein-2 (HRP2) capture test
[17,18] and polymerase chain reaction (PCR) [18-20].
Placental histology is considered the "gold standard" of
malaria diagnosis in pregnancy for epidemiological or
biological study purposes, because it can show signs of
active (presence of IEs only in the IVS), active chronic
(presence of IEs and pigment in monocytes) or past
(malarial pigment in fibrin) infections [21,22]. However,
due to limited technical expertise, such testing is rarely
available in endemic areas. Most studies in sub-Saharan
Africa have relied on the results of the placental blood
smear [9], the sensitivity of which is low compared with
placental histopathology [16].
This study: i) determined and compared malaria infection
at delivery in maternal peripheral blood, placental blood
and placental histological sections; ii) assessed the epide-
miological and clinical significance of P. falciparum infec-
tions detected by blood smear microscopy, histology only
and past infection, as well as risk factors associated with
malaria infection at delivery.
Methods
Study area and population
The study was conducted in the Mutengene health area
from March to October 2007. Mutengene is a semi-urban,
road-junction town, located in the Mt Cameroon region,
Fako Division of the South West Province of Cameroon.
The Mutengene medical centre is the only government-
owned institution that offers antenatal care, preventive
and curative services at affordable cost in the health area.
This town is located at about 220 m above sea level and
has a heterogeneous population of approximately 40,000
inhabitants who originate mainly from neighbouring
provinces in search of its fertile farmland and business
opportunities [11,23].
The Mt Cameroon region has an equatorial climate made
up of a long rainy season that starts in March and ends in
October with maximum rainfall in August and Septem-
ber. The dry season starts in late October and ends in Feb-
ruary. The mean value of the minimum temperature
varies between 20.0°C in December and 18.0°C in
August and the mean value of the maximum temperature
ranges between 35.0°C in February and 30.0°C in March
[23]. Mutengene is characterized by mean temperatures of
25.1°C and mean relative humidity of 83.1% (Cameroon
Development Corporation (CDC) weather records,
2004).
The Mt Cameroon region is hyperendemic for malaria,
with P. falciparum being the predominant malaria parasite
species [24]. A previous study on malaria in pregnancy in
Mutengene from 1998–2001 recorded malaria parasite
rates of 32.7%, 33.7% and 7.8% in maternal, placental
and cord blood respectively [13]. In addition, this study
showed that anaemia is a major health problem in this
area and malaria contributes about 50% of the anaemic
cases [11]. Intermittent preventive treatment in pregnancy
(IPTp), using regular treatment doses of the antimalarial
sulphadoxine/pyrimethamine (SP) was introduced as a
national policy in Cameroon in 2003 and implementa-
tion is still in progress [25]. The study received ethical
clearance from the Delegation of Public health, Buea,
South West Province.
Sample collection and processing
Pregnant women reporting for delivery at the Mutengene
maternity health centre and who consented to participate
in the study were enrolled. Expectant mothers with evi-
dence of chronic illness and complicated pregnancy
(hypertension, preeclampsia, diabetes) were not eligible
and cases of multiple pregnancies were excluded. All
maternal and infant characteristics (age, gravidity, gesta-Malaria Journal 2009, 8:126 http://www.malariajournal.com/content/8/1/126
Page 3 of 9
(page number not for citation purposes)
tional age, birth weights, number of antenatal visits, SP
dosage, and history of fever attack during pregnancy) were
documented using a standard questionnaire. IPT/SP dur-
ing pregnancy is administered during antenatal visits
under the supervision of a midwife who records and signs
in patients' antenatal case report book. SP dosage and
compliance and history of fever attack were confirmed
from the patient's medical record book and by personal
interview. Human immunodeficiency virus (HIV) infec-
tion status was known for mothers recruited. Women in
this setting are offered routine confidential HIV testing at
first antenatal clinic (ANC) visit, but testing was done at
delivery for women who had no antenatal follow-up or
had enrolled in maternity clinics out of the study area
with no ANC cards. We did not obtain informed consent
to publish data on HIV status of the participants.
Maternal peripheral venous blood (2 ml) was collected by
venopuncture within 24 hours of parturition and used to
prepare thick blood films. Immediately following deliv-
ery, the placenta was obtained and a small piece of placen-
tal tissue (0.5 cm3) excised from the centre of the placenta
and used to prepare impression smears. A larger biopsy
specimen of placental tissue (2 by 2 by 1 cm) was fixed in
10% neutral buffered formalin for histopathological stud-
ies.
Parasitological examination
Placental impression smears were fixed in methanol and
together with thick films stained for 20 mins with 5%
Giemsa (Sigma). Fixed placental biopsies were transferred
to the Anatomy and Pathology (ANAPATH) Laboratory,
University of Yaoundé I Teaching Hospital (CHU),
Yaoundé, Cameroon, where they were processed, embed-
ded in paraffin wax and sectioned onto slides by standard
techniques. Sections were later stained with haematoxy-
lin-eosin stain for detection of active and past infections.
Microscopic examination of blood smears was done
under oil immersion for parasite detection and 200 high
power fields were examined before the smear was consid-
ered negative. Parasites were counted against 200 leuco-
cytes assuming an average leucocyte count of 8,000 per
microlitre of blood [26]. To determine the percentage of
malaria parasitaemia from placental impression smears,
malaria parasite-infected red cells were counted against
1,000 erythrocytes.
Placental histological sections were first examined by the
one of the investigators (JKA) and later confirmed by a
more experienced histopathologist (BN) without knowl-
edge of the blood film microscopy results. One thousand
intervillous cells (IVS) were counted to determine the
level of parasitaemia in placenta tissue sections. Past
infection was defined as the presence of malaria pigment
in fibrin or monocyte/macrophage without malaria para-
sites [14]. Histology was re-examined in all cases in which
histology and blood film results were in disagreement.
Sections were observed under polarised light to assess the
presence of malaria pigment [27].
Haematological analysis
Heparinized, microhaematocrit tubes were filled with a
sample of peripheral blood and centrifuged using a micro-
haematocrit centrifuge. The haematocrit (packed cell vol-
ume (PCV) was read using haematocrit reader
(Hawksley). Haemoglobin concentration was calculated
from PCV values as described by Topley [28]. Anaemia
was defined as Hb < 11.0 g/dl [29].
Statistical analyses
All data were entered and analysed using SPSS version
11.5. Malaria infection at delivery was classified as micro-
scopic parasitaemia detected by blood smear microscopy,
parasitaemia by histology only, past infection and no
malaria. Associations of the different types of malaria
diagnosis with age group, parity, use and doses of IPTp-SP
and history of fever attack were evaluated using Pearson
Chi-Square (χ2) test, odds ratio (OR) test in univariate
analyses and logistic regression in multivariate analyses.
Differences in group means were assessed using ANOVA,
Mann-Whiney U test or Kruskall Wallis test. Age and par-
ity was categorized as follows: age (≤ 20, 21–25, >25)
years and parity (primiparae, secundiparae and multi-
parae (≥ 3 pregnancies), use of SP (no SP, 1 dose and ≥ 2
doses), fever history (fever attack = Yes, No fever attack =
No). Statistical significance was set at p ≤ 0.05.
Results
Description of study participants
A total of 306 women delivering at the Mutengene maten-
ity ward were recruited. The mean age of the mothers was
23.8 ± 5.2 (range; 14–40) years, where primiparae (19.5 ±
2.4) were significantly younger (p < 0.001) compared
with secundiparae (22.6 ± 3.0) and multiparae (28.2 ±
4.6). Among the women, 90.1% (272/302) reported tak-
ing IPTp-SP during pregnancy. For women with number
of doses recorded, 47.8% (129/270) had taken one dose,
52.2% (141/270) took two or more doses and 9.9% (30/
302) did not take SP during the entire pregnancy period.
Peripheral blood was collected from 287. Reported his-
tory of fever was 43.6% (125/287). One hundred and sev-
enty-six (63.3%; 278) women were anaemic at delivery
and the prevalence of low birth weight was 5.6% (17/
306). The prevalence of HIV infection among women
recruited was 5.6%; (17/306).
Detection and prevalence of malaria infection
Sixteen women (5.6%; 16/287) had malaria parasite
infection diagnosed by peripheral blood microscopy. Sev-
enty-eight (25.5%; 78/306) had placental infection diag-Malaria Journal 2009, 8:126 http://www.malariajournal.com/content/8/1/126
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nosed by placental blood smear examination. Of the 25%
diagnosed by placental blood smear, 19.6% (60/306)
were with active infection while 5.9% (18/306) had past
infection. Placental histological examination detected 185
(60.5%, 185/306) placental malaria positive women. Of
these, 33.7% (103) had active placental infections while
26.8% (82) had past infection. Overall, 39.2% (120/306)
had active P. falciparum infection, defined as the presence
of malaria parasites as detected in thick peripheral blood,
placental impression blood films or placental tissue sec-
tions. Of the active infections, 44.2% (53) were detected
by histology only and 55.8% (67) by blood smear micro-
scopy and histology. Of the 82(26.8%) women with past
infection on histology, 12 were positive for malaria para-
sites on blood smear microscopy (3 positive on peripheral
blood and 9 on placental blood) thus the overall preva-
lence of past infection was 22.9% (70). The cumulative
prevalence of malaria infection at delivery (total number
of women positive for malaria either by histology or
peripheral and placental blood smear examination was
62.1% (190/306).
Placental histology detected all but three of the placental
infections detected by placental blood smear examina-
tion, as well as all but two of the malaria infection
detected by peripheral blood smear; giving a sensitivity of
97.4%. One hundred and ten women with histological
evidence of placental infection were missed on placental
blood smear, which had a sensitivity of 41.5%. One hun-
dred and sixty-one women positive by placental histology
were missed on peripheral blood examination, which had
a sensitivity of 8% (Figure 1). The overall prevalence of
placental malaria at delivery was 61.4% (188/306). There
was a significant positive correlation between parasitae-
mia levels determined by placental blood smear and tis-
sue sections (r = 0.757; p < 0.001). Among the women in
whom malaria parasite was detected by histology only,
the median (range) placental parasite density was 0.38%
(0.10 to 3.2%) lower (p < 0.001) compared to that for
women with positive placental blood smears (0.83%;
range, 0.11 to 57.27%). Generally, placental parasites
were usually scarce: 66.1% (76/115) of actively infected
placentas had parasitaemia less than 1% whereas only
12.2% (14/115) showed 10% or more parasitized eryth-
rocytes.
Factors influencing the prevalence of malaria infection at 
delivery
Microscopically detected parasitaemia was the only clini-
cally relevant malaria infection at delivery and factors
influencing its presence were analysed (Table 1). In mul-
tivariate analysis, younger age (≤ 20 years) and reported
Frequency distribution of malaria infection in peripheral blood, placental blood and placental tissue sections Figure 1
Frequency distribution of malaria infection in peripheral blood, placental blood and placental tissue sections. 
Malaria infection was defined as presence of malaria parasites, malaria pigment (haemozoin) in monocytes and/or fibrin 
detected by microscopy in maternal peripheral blood, placental blood and placental tissue sections from parturient women.
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fever history were independent risk factors associated with
microscopic parasitaemia while the use of ≥ 1 SP doses
was associated with reduction in the prevalence of infec-
tion. Parity was not associated with microscopic infec-
tions neither in univariate nor multivariate analyses.
Nevertheless, past infections were common (χ2 = 6.328; p
= 0.042) in primiparous (31.6%) compared to secundipa-
rous (21.1%) and multiparous (17.4%) women. The pres-
ence of infections detected by histology only (low-grade
parasitaemia) was significantly associated with age (>20
years) (OR = 0.34, 95% CI = 0.15 – 0.75) where infections
detected by histology only were more common (χ2 =
7.616; p = 0.006) in women > 20 years old (20.8%) than
in those ≤ 20 years (8.5%). Parity, SP dosage, or fever his-
tory were not associated with the prevalence of low-grade
infection.
The effect of malaria infection status at delivery on infant 
birth weight and maternal anaemia
The mean birth weights of babies did not differ with
malaria infection status, while mean haemoglobin con-
centrations were significantly lower in women with
microscopically detected infection compared to unin-
fected women (Table 2). Similarly, microscopic parasitae-
mia (OR = 2.74, 95% CI = 1.33–5.62) was a significant (p
= 0.006; 49/62) risk factor for maternal anaemia at deliv-
ery, but low-grade parasitaemia (OR = 0.61, 95% CI =
0.31–1.22; p = 0.162; 22/48) and past infections (OR =
1.73, 95% CI = 0.89 – 3.39; p = 0.106; 43/61) did not sig-
nificantly increase the risk of anaemia.
Table 1: Risk factors of microscopic parasitaemia
Factors % positive Univariate analysis Multivariate analysis
OR (95% CI)* P OR (95% CI) † P
Age (years)(n)
≤ 20 (94) 31.9 (30) 2.69 (1.34 – 5.41) 0.005 4.61 (1.47 – 14.70) 0.01
21–25 (108) 18.5 (20) 1.30 (0.63 – 2.71) 0.478 2.03 (0.80 – 5.20) 0.137
>25 (101) 14.9 (15) Reference
Parity (n)
I (95) 29.5 (28) 1.78 (0.95 – 3.35) 0.072 0.61 (0.22 – 1.69) 0.337
II (90) 17.8 (16) 0.92 (0.46 – 1.87) 0.820 0.40 (0.15 – 1.06) 0.064
≥ III (121) 19.0 (23) Reference
SP dosage (n)
≥ 2 (141) 14.9 (21) 0.26 (0.11 – 0.62) 0.002 0.18 (0.06 – 0.52) 0.002
1 (129) 24.0 (31) 0.47 (0.21 – 1.09) 0.076 0.31 (0.11 – 0.88) 0.028
No SP (30) 40.0 (12) Reference
Fever history (n)
Yes (125) 28.8 (36) 2.45 (1.36 – 4.40) 0.002 2.98 (1.58 – 5.73) 0.001
No (162) 14.2 (23) Reference
OR = odds ratio; CI = confidence interval
* Estimated by Pearson-Chi-Square
† Estimated by multivariate logistic regression including all risk factors in the table
Table 2: Comparison of birth weight (kg) and maternal haemoglobin levels (g/dl) according to presence or absence of malaria infection 
as detected by microscopy and histology
Infection classificationa Birth weight (kg) (± SD) Hb (g/dl) (± SD)
Malaria on microscopy 3.18 ± 0.54 (67)b 9.59 ± 1.87 (62)***c
Malaria on histology only 3.40 ± 0.49 (53)d 10.90 ± 1.38 (48)e
Past malaria 3.22 ± 0.52 (70)f 10.33 ± 1.29 (61)g
No malaria 3.31 ± 0.12 (116) 10.57 ± 1.67 (107)
*** Significant
a Malaria on microscopy: parasites identified by peripheral and placental blood
microscopy; malaria on histology only, parasites identified by histology only but not blood smear microscopy; past malaria infection, malaria pigment 
identified by histology with negative blood film microscopy; no malaria, no parasites by blood smear microscopy nor placental histology.
b P = 0.09 c P < 0.001, d P = 0.283, e P = 0.229, f P = 0.214, gp = 0.346  represent comparison with placentas with no P. falciparum infection.Malaria Journal 2009, 8:126 http://www.malariajournal.com/content/8/1/126
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Discussion
This study determined the prevalence of malaria infection
and parasite density in Cameroonian parturient women
using maternal peripheral blood microscopy, placental
blood microscopy and placental histology. The epidemio-
logical and clinical relevance of the different types of
malaria diagnosis as well as some risk factors associated
with malaria infection were investigated.
Overall, pregnant women in this semi-urban area of Cam-
eroon were frequently (62.1%) exposed to P. falciparum
infection during pregnancy. Using blood smear micros-
copy, 21.9% of the women were found to harbour malaria
parasites at delivery similar to findings reported in
Yaoundé [17,19]. Malaria parasitaemia rate increased to
39.2% when the results of placental histology were added.
Furthermore, microscopy of peripheral blood missed
more microscopic placental infections, with 49 out of 60
women having a negative peripheral blood film. The
observed sensitivity of placental histology is in accord
with previous reports [15,16,30] and emphasis the gross
underestimation of placental malaria infection by periph-
eral blood microscopy in pregnant women living in
endemic areas. It is possible that peripheral parasitaemia
may remain below the levels of microscopic detection
while parasites may be harboured by the placenta and
evade circulation. Nevertheless some studies have
reported high sensitivities of peripheral blood immuno-
chromatographic (ICT) strip test that detects P. falciparum
histidine-rich protein 2 (HRP-2) [17,31] and PCR, that
amplifies P. falciparum-specific DNA for detection of low-
level parasitemia or circulating genetic material [32] com-
pared to peripheral blood microscopy in detecting micro-
scopically confirmed placental Plasmodium falciparum
[19,31]. Malaria in pregnancy has significant adverse
effects on the mother and foetus. Consequently, early and
accurate diagnosis of malaria in pregnancy is absolutely
imperative. Obtaining results quickly from the examina-
tion of blood samples from pregnant women with sus-
pected malaria is now made possible by the use of rapid
malaria diagnostic tests (RDTs), although their use in
developing countries is limited by their high cost and
availability [33].
There was a significant positive correlation between para-
sitaemia levels determined by placental blood smear and
tissue sections (r = 0.757; p < 0.001), the median placental
parasitaemia levels being higher in placental blood
smears (0.83%) compared to that detected in placental
tissue sections (0.38%). Two concepts are suggested.
Firstly, impression smears correlate quite well with histol-
ogy. Secondly, infection detected only by histology is
lower level and potentially less significant than infection
found on impression smears.
It is well established that primigravidae are indisputably
at greater risk of malaria infection during pregnancy in sta-
ble malaria regions [34]. In the present study, parity was
associated only with past infections. Similar to previous
studies, age (≤ 20 years old) was an independent risk fac-
tor for microscopic parasitaemia after adjusting for parity
[10,35-38]. Furthermore, parity had no effect on the prev-
alence of low grade parasitaemia in pregnant women sim-
ilar to findings reported elsewhere [16,19] but women >
20 years had higher prevalence of low-grade parasitaemia
than women ≤ 20 years old). This suggests that age-asso-
ciated immunity may play an important role in limiting P.
falciparum to low parasite densities in areas of high and
stable transmission [39]. The relationship between the
role of age as a determinant of immunity and vaccine
studies is not really clear. It is suggested that non-preg-
nancy-specific vaccines might help teenage mothers [40],
but at present it is not clear whether vaccines like RTS, S is
meant rather than VAR2CSA vaccines.
It is generally assumed that in areas of stable transmission,
parasitaemic pregnant women are rarely symptomatic,
and that severe disease or death from malaria is extremely
unusual [41]. However, this assumption has been based
on few studies and symptoms suggestive of malaria
among pregnant women attending maternity clinics are
frequent [42]. Headache, arthromyalgias and history of
fever are the most common symptoms reported in preg-
nant women [42]. In this study, history of fever attack was
common (44%) in women during pregnancy and was
associated with approximately three-fold increased risk of
microscopic parasitaemia at delivery. Future studies are
needed to evaluate the clinical presentation of malaria
episodes during pregnancy in stable transmission areas to
better control the disease. Secondly, the lack of appropri-
ate or timely treatment of symptomatic malaria in preg-
nancy may lead to adverse pregnancy outcome.
Women with blood smear microscopically detectable
malaria were likely to be anaemic and had a mean haemo-
globin concentration of 0.98 g/dl lower than that of unin-
fected women. Similar to findings reported elsewhere
[16,19,31] blood film microscopy identified women at
highest risk of anaemia. This study did not show an asso-
ciation between infection detected by histology only and
anaemia nor a change in mean haematocrit levels.
Equally, several studies, [16,19,37] failed to obtain an
association between subpatent P. falciparum infection in
both peripheral and placental blood and increased risk of
anaemia. On the contrary, in Ghana, as reported by Mock-
enhaupt  et al [31,43], submicroscopic infections were
found to be a risk factor for maternal anaemia. The impact
of subpatent malaria infections on anaemia might vary
with different malaria endemicity levels and therefore
with the level of pre-pregnancy acquired malaria immu-Malaria Journal 2009, 8:126 http://www.malariajournal.com/content/8/1/126
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nity [37]. Anaemia may be caused by an increase in den-
sity of parasitaemia rather than the mere presence of
parasite infection.
In Malawi, Rogerson et al [16] showed that birth weights
of newborns differed significantly with a diagnosis of
malaria. Further, the prevalence of LBW babies was signif-
icantly higher for women with blood film microscopically
detectable infection compared to those with no parasites
by blood film microscopy or placental histology. The
prevalence of LBW in the study area was particularly low
thus it is possible that the small sample size did not pro-
vide the power needed to detect the effect of malaria on
LBW. In other areas, LBW among women with malaria
infection is frequently around 20% and close to 10% in
those without [16]. This may explain the lack of associa-
tions. Placental monocytes and fibrin containing malaria
pigment have been shown to play important roles in the
pathogenesis of pregnancy-associated malaria [22]. There
is the need for prospective studies in the study area that
will examine the causal roles of monocyte and fibrin con-
taining pigment in the pathogenesis of decreased birth
weight and maternal anaemia.
It is not surprising that women who reported to have
received one or more doses of SP had a decreased risk of
microscopic parasitaemia at delivery than those who had
no SP during pregnancy. Furthermore, two or more doses
of SP significantly reduce the prevalence of microscopic
parasitaemia among pregnant women similar to findings
of previous studies [44,45]. The prevalence of peripheral
malaria parasitaemia (5.6%) and placental malaria para-
sitaemia (25.5%) as detected by blood smear microscopy
is low compared to that previously reported in the same
community where peripheral and placental malaria para-
sitaemia (33.2% and 33.6% respectively) were similar
[13]. This study was carried out from 1998–2001 when
pyrimethamine chemoprophylaxis had been recom-
mended for use in pregnancy. It can be observed from the
current study that maternal peripheral and placental
malaria infection at delivery has decreased in this area
confirming that IPT with SP may be effective in reducing
malaria parasitaemia in pregnancy after implementation.
Similar to findings reported elsewhere [35,45-47].
Approximately half of the women in the study received ≤
1 SP dose. Thus a study to evaluate the coverage of IPTp-
SP in this area in order to identify facilitating factors and
operational challenges for scaling up IPT delivery is
imperative.
Conclusion
In summary, malaria in pregnancy was most sensitively
diagnosed by placental histology. Younger age and history
of fever attack during pregnancy were independent signif-
icant risk factors associated with microscopic parasitaemia
at delivery. Blood smear microscopy identified a subset of
women with malaria who had a high risk of anaemia
whereas low-grade parasitaemia detected by histology
only and past infection were not associated with maternal
anaemia at delivery. Improving IPTp-SP coverage and
adherence will substantially reduce malaria parasitaemia
and maternal anaemia in pregnant women in this area.
Proper diagnosis as well as ensuring appropriate and
timely treatment of symptomatic malaria in pregnancy is
recommended.
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